Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.
Strain:? BALB/c (B cell); BALB/c (myeloma)
Graziano RF, Fanger MW. FcgammaRI and FcgammaRII on monocytes and granulocytes are cytotoxic trigger molecules for tumor cells. J. Immunol. 139: 3536-3541, 1987. PubMed: 2960735
Petroni KC, et al. Modulation of human polymorphonuclear leukocyte IgG Fc receptors and Fc receptor-mediated functions by IFN-gamma and glucocorticoids. J. Immunol. 140: 3467-3472, 1988. PubMed: 2966197
Fanger MW, et al. Monoclonal antibodies to FC receptors for immunoglobulin G on human mononuclear phagocytes. US Patent 4,954,617 dated Sep 4 1990
Fanger MW, et al. Cytotoxicity mediated by human Fc receptors for IgG. Immunol. Today 10: 92-99, 1989. PubMed: 2525910
Shen L, et al. Polymorphonuclear leukocyte function triggered through the high affinity Fc receptor for monomeric IgG. J. Immunol. 139: 534-538, 1987. PubMed: 2955043
Shen L, et al. Heteroantibody-mediated cytotoxicity: antibody to the high affinity Fc receptor for IgG mediates cytotoxicity by human monocytes that is enhanced by interferon-gamma and is not blocked by human IgG. J. Immunol. 137: 3378-3382, 1986. PubMed: 2946759
Anderson CL, et al. Monoclonal antibodies to Fc receptors for IgG on human mononuclear phagocytes. Antibody characterization and induction of superoxide production in a monocyte cell line. J. Biol. Chem. 261: 12856-12864, 1986. PubMed: 3017990
Ball ED, Fanger MW. Bispecific molecules for use in inducing antibody dependent effector cell-mediated cytotoxicity. US Patent 5,833,985 dated Nov 10 1998
Tempest PR, et al. Humanized antibodies to Fc receptors for immunoglobulin G on human mononuclear phagocytes. US Patent 6,500,931 dated Dec 31 2002
